Qualidade de vida e perfil sociodemográfico e clínico de pacientes com câncer de mama e próstata
DOI:
https://doi.org/10.15253/2175-6783.20232489231Palabras clave:
Neoplasias da Mama; Neoplasias da Próstata; Qualidade de Vida; Enfermagem Oncológica; Cuidados de Enfermagem.Resumen
Objetivo: avaliar a associação entre a qualidade de vida relacionada à saúde e as características sociodemográficas e clínicas de pacientes com câncer de mama e próstata. Métodos: estudo transversal com 305 pacientes. Foram utilizados o European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, Quality of Life Questionnaire Breast Cancer e um instrumento estruturado. Realizaram-se análises estatísticas, descritiva e inferencial. Resultados: observou-se prevalência de faixa etária entre 50 e 69 anos, casados, 13 anos ou mais de estudo, aposentados, com renda de até dois salários mínimos, com câncer de mama em radioterapia. Houve associação significante entre Escala de Saúde Global e sexo e conjugalidade; Escala Funcional e faixa etária e renda familiar; Escala de Sintomas e sexo, faixa etária, tipo de câncer, tratamento atual; Escala de Saúde Global e tipo de câncer, tratamento atual, tempo de tratamento, falta de acompanhante e número de comorbidades. Conclusão: a qualidade de vida relacionada à saúde é influenciada negativamente pelas características sociodemográficas e clínicas de pacientes com câncer de mama e próstata. Contribuições para a prática: os dados fornecem subsídios para concepção de um plano individualizado de cuidados de enfermagem.
Citas
Santos MO, Lima FCSD, Martins LFL, Oliveira JFP, Almeida LMD, Cancela MC. Estimated cancer incidence in Brazil, 2023-2025. Rev Bras Cance- rol. 2023;69(1):e-213700. doi: https://dx.doi.org/10.32635/2176-9745.RBC.2023v69n1.3700
Carlos EA, Borgato JA, Garbio DC. Evaluation of the quality of life of cancer patients undergoing chemotherapy. Rev Rene. 2022;23:e71133. doi: https://doi.org/10.15253/2175-6783.20222371133
Salvetti MG, Machado CSP, Donato SCT, Silva AMD. Prevalence of symptoms and quality of life of cancer patients. Rev Bras Enferm. 2020;73(2):e20180287. doi: http://doi.org/10.1590/0034-7167-2018-0287
Silveira FM, Wysocki AD, Mendez RD, Pena SB, Santos EM, Malaguti-Toffano S, et al. Impact of chemotherapy treatment on the quality of life of patients with cancer. Acta Paul Enferm. 2021;34:eAPE00583. doi: https://dx.doi.org/10.37689/actaape/2021AO00583
Lima EOL, Silva MMD. Quality of life of women with locally advanced or metastatic breast cancer. Rev Gaúcha Enferm. 2020;41:e20190292. doi: https://doi.org/10.1590/1983-1447.2020.20190292
Medeiros MBD, Silva RMCRA, Pereira ER, Melo SHDS, Joaquim FL, Santos BMD, et al. Perception of women with breast cancer undergoing chemotherapy: a comprehensive analysis. Rev Bras Enferm. 2019;72(Suppl 3):103-10. doi: https://doi.org/10.1590/0034-7167-2018-0165
Rocha DM, Pedrosa AO, Oliveira ACD, Benício CD, Santos AMD, Nogueira LT. Predictors and quality of life in patients with radiodermatitis: a longitudinal study. Acta Paul Enferm. 2021;34:eAPE01063. doi: http://dx.doi.org/10.37689/actaape/2021AO01063
Salgado NDM, Silva FRF, Souza JCFD, Chagas JMA, Botelho LL, Gonçalves LSF, et al. Psychological impacts of mastectomy due to breast cancer in women’s lives. Rev Eletr Acervo Cientif. 2021;31:1-6. doi: https://doi.org/10.25248/REAC.e8386.2021
Bardaweel SK, Akour AA, Al-Muhaissen S, AlSalamat HA, Ammar K. Oral contraceptive and breast cancer: do benefits outweigh the risks? A case - control study from Jordan. BMC Womens Health. 2019;319(1):72. doi: https://dx.doi.org/10.1186/s12905-019-0770-x
Araújo JS, Zago MMF. Masculinities of prostate cancer survivors: a qualitative metasynthesis. Rev Bras Enferm. 2019;72(1):231-40. doi: http://dx.doi.org/10.1590/0034-7167-2017-0730
Abedalrahman SK, Ali BM, Al-Khalidy NAI, Al-Hashimi AS. Risk factors of breast cancer among Iraqi women. J Contemp Med Sci. 2019;3(5):149-53. doi: https://doi.org/10.22317/jcms.v5i3.609
Michels FAS, Latorre, MRDS, Maciel MS. Validity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer. Rev Bras Epidemiol. 2013;16(2):352-63. doi: https://doi.org/10.1590/S1415-790X2013000200011
Gregorowitsch ML, Ghedri A, Young-Afat DA, Bijlsma R, Baas IO, Van Schaik‑van de Mheen C, et al. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients. Breast Cancer Res Treat. 2019;175(2):429-41. doi: https://dx.doi.org/10.1007/s10549-019-05149-4
Oliveira DAL, Silva LBF, Alves SKM, Guerra MCGC, Ramos VP. Social network support for women with breast cancer undergoing chemotherapy. Rev Enferm Digit Cuid Prom Saúde. 2023;8:1-8. doi: https://doi.org/10.5935/2446-5682.20230186
Dano D, Hénon C, Sarr O, Ka K, Ba M, Badiane A, et al. Quality of life during chemotherapy for breast cancer in a west African population in Dakar, Senegal: a prospective study. J Glob Oncol. 2019;5:1-9. doi: https://ascopubs.org/doi/full/10.1200/JGO.19.00106
Nunes MAH, Ceolim MF. Quality of sleep and symptom cluster in cancer patients undergoing chemotherapy treatment. Cogitare Enferm. 2019;24:e58046. doi: http://dx.doi.org/10.5380/ce.v24i0.58046
Silva PR, Cruz LAP, Nascimento TG, Gozzo TO. Sleep quality and fatigue in women with breast cancer during chemotherapy. Rev Enferm UFSM. 2019;9:e20. doi: https://dx.doi.org/10.5902/2179769232732
Bedoya AM, Arcila AL, Cardona-Arias JA. Factores de riesgo para el cáncer de mama. Rev Cubana Obstet Ginecol [Internet]. 2019 [cited May 23, 2023];45(2):e370. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2019000200002&lng=es
Pereira LDA, Musso MAA, Calmon MV, Souza CBD, Zandonade E, Costa Neto SB, et al. Quality of life of women with breast cancer in the preoperative, postoperative and chemotherapy treatments. Braz J Hea Rev. 2021;4(2):6647-62. doi: https://doi.org/10.34119/bjhrv4n2-216
Tran TH, Trinh NL, Hoang Y, Nguyen TL, Vu TT. Health-related quality of life among vietnamese breast cancer women. Cancer Control. 2019;26(1):1073274819862787. doi: http://doi.org/10.1177/1073274819862787
Vassilievitch AC, Amorim BF, Kameo SY, Silva GO, Sawada NO. Sociodemographic and quality of life analysis related to the health of women with breast cancer after chemotherapy treatment. RG&PP. 2020;10(1):139-55. doi: https://dx.doi.org/10.11606/rgpp.v10i1.175028
Sant’Anna SS, Rosa RS, Gomes LOS, Souza FS, Biondo CS. Repercussions in the family context of patients with prostate cancer. Rev Salud Pública. 2022;24(5):1-8. doi: https://doi.org/10.15446/rsap.v24n5.65435
Silva WA, Ramos MJO, Carvalho MGMD, Dinizio VGO, Dantas VGV, Kameo SY. Cryotherapy for reduction of chemotherapy-induced alopecia: use in women with breast cancer. Rev Soc Dev. 2022;11(17):e117111738926. doi: http://dx.doi.org/10.33448/rsd-v11i17.38926
Imran M, Al-Wassia R, Alkhayyat SS, Baig M, Al-Saati BA. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: a tertiary care center survey in the western region of Saudi Arabia. PLoS One. 2019;14(7):e0219093. doi: https://dx.doi.org/10.1371/journal.pone.0219093
Ligt KM, Heins M, Verloop J, Ezendam NPM, Smorenburg CH, Korevaar JC. The impact of health symptoms on health‑related quality of life in early‑stage breast cancer survivors. Breast Cancer Res Treat. 2019;178(3):703-11. doi: https://doi.org/10.1007/s10549-019-05433-3
Lee Y, Baek JM, Ye-Won J, Eun-Ok IM. Illness perception and sense of well-being in breast cancer patients. Patient Prefer Adherence. 2019;13:1557-67. doi: https://doi.org/10.2147/PPA.S225561
Castillo-Otiniano CC, Yan-Quiroz EF. Hipertensión arterial y diabetes mellitus como factores de riesgo para el cáncer de mama. Rev Cuerpo Méd. 2019;12(1):35-9. doi: https://doi.org/10.35434/rcmhnaaa.2019.121.483
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Rev Rene
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.